MoonLake Immunotherapeutics (MLTX)

Price & Market Data

Price: $18.19

Daily Change: -$0.65 / 3.57%

Daily Range: $17.83 - $19.17

Market Cap: $1,339,064,064

Daily Volume: 1,552,836

Performance Metrics

1 Week: 6.94%

1 Month: -1.30%

3 Months: 16.45%

6 Months: 71.12%

1 Year: -54.73%

YTD: 38.01%

About MoonLake Immunotherapeutics (MLTX)

Discover the market presence of MoonLake Immunotherapeutics (MLTX). Price: 18.19, daily change: -$0.65 / 3.57%. Market cap: 1,339,064,064. Performance across all periods for a clear financial view.

Company Details

Employees: 130

Sector: Health technology

Industry: Pharmaceuticals: major

Country: Switzerland

Details

MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.

Selected stocks

Aurora Cannabis Inc. (ACB)

KVH Industries, Inc. (KVHI)

Deluxe Corporation (DLX)

Core AI Holdings, Inc. (CHAI)

DarioHealth Corp. (DRIO)